Annexon receives prime designation from the ema for anx007 for the treatment of geographic atrophy

Prime designation granted based on phase 2 archer trial results, which showed meaningful preservation of visual function in patients with geographic atrophy
ANNX Ratings Summary
ANNX Quant Ranking